Stock Research: Torrent Pharmaceuticals

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Torrent Pharmaceuticals

BSE:500420 INE685A01028
44
  • Value
    8
  • Growth
    99
  • Safety
    Safety
    13
  • Combined
    21
  • Sentiment
    80
  • 360° View
    360° View
    44
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Torrent Pharmaceuticals Limited is an India-based company focused on pharmaceutical research, development, manufacturing, marketing, and distribution of branded and generic formulations. It operates in therapeutic segments including cardiovascular, central nervous system, gastrointestinal, anti-diabetes, pain management, gynecology, and dermatology, with brands like Tedibar and Macrotor. The company operates in India and internationally, with manufacturing facilities in Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh, and Sikkim. In the last fiscal year, the company had a market cap of $13620 million, profits of $1010 million, revenue of $1348 million, and 16107 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 44 (better than 44% compared with alternatives), overall professional sentiment and financial characteristics for the stock Torrent Pharmaceuticals are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Torrent Pharmaceuticals. The consolidated Growth Rank has a good rank of 99, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 99% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 80, which means that professional investors are more optimistic about the stock than for 80% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 13, which means that the share price of Torrent Pharmaceuticals is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 87% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 8, which means that the company has a financing structure that is riskier than those of 92% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Low Emissions
Low Waste
Recycling
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
13 13 21 39
Growth
99 89 77 15
Safety
Safety
8 5 1 1
Sentiment
80 43 88 77
360° View
360° View
44 17 37 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
66 40 63 51
Opinions Change
28 20 42 40
Pro Holdings
n/a 66 89 69
Market Pulse
83 42 71 65
Sentiment
80 43 88 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
13 13 21 39
Growth
99 89 77 15
Safety Safety
8 5 1 1
Combined
21 11 11 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
13 19 22 33
Price vs. Earnings (P/E)
19 11 25 33
Price vs. Book (P/B)
11 10 14 34
Dividend Yield
43 50 53 51
Value
13 13 21 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
67 78 63 56
Profit Growth
77 60 76 26
Capital Growth
100 74 35 4
Stock Returns
77 83 77 53
Growth
99 89 77 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
23 24 14 14
Refinancing
6 4 4 6
Liquidity
37 28 26 22
Safety Safety
8 5 1 1

Similar Stocks

Discover high‑ranked alternatives to Torrent Pharmaceuticals and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

L&T Finance Holdings

BSE:533519
Country: India
Industry: Other Financial Services
Size: Medium
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.